Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLLEGIUM PHARMACEUTICAL, INC Director's Dealing 2021

Mar 4, 2021

32163_dirs_2021-03-03_63a14e70-3cc3-4e0e-bb3a-337ce338f69b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2018-01-12

Reporting Person: Fleming Alison B (Chief Technical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-12 Common Stock M 1747 $0.9 Acquired 157911 Direct
2018-01-12 Common Stock S 1747 $21 Disposed 156164 Direct
2018-01-12 Common Stock M 5753 $0.48 Acquired 161917 Direct
2018-01-12 Common Stock S 5753 $21 Disposed 156164 Direct
2018-01-19 Common Stock M 64 $0.9 Acquired 156228 Direct
2018-01-19 Common Stock S 64 $23 Disposed 156164 Direct
2018-01-19 Common Stock M 1811 $0.9 Acquired 157975 Direct
2018-01-19 Common Stock S 1811 $23 Disposed 156164 Direct
2018-01-19 Common Stock M 1449 $3.31 Acquired 157613 Direct
2018-01-19 Common Stock S 1449 $23 Disposed 156164 Direct
2018-05-10 Common Stock S 1400 $27 Disposed 154764 Direct
2021-03-01 Common Stock S 6011 $23.36 Disposed 148753 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-12 Stock Option (Right to Purchase) $0.9 M 1747 Disposed 2019-04-23 Common Stock (1747) Direct
2018-01-12 Stock Option (Right to Purchase) $0.48 M 5753 Disposed 2023-01-24 Common Stock (5753) Direct
2018-01-19 Stock Option (Right to Purchase) $0.9 M 64 Disposed 2019-04-23 Common Stock (64) Direct
2018-01-19 Stock Option (Right to Purchase) $0.9 M 1811 Disposed 2020-02-26 Common Stock (1811) Direct
2018-01-19 Stock Option (Right to Purchase) $3.31 M 1449 Disposed 2021-02-08 Common Stock (1449) Direct

Footnotes

F1: Certain transactions reported in this Form 4 are late due to an administrative error.

F2: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

F3: The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018.

F4: The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2020.

F5: The option was fully vested and exercisable as of January 12, 2018.

F6: The option was fully vested and exercisable as of January 19, 2018.